An update on hybrid drugs in cardiovascular drug research-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An update on hybrid drugs in cardiovascular drug research

Published:2008-12 Issue:12 Volume:3 Page:1397-1408
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Calderone Vincenzo

Publisher

Informa Healthcare

Subject

Drug Discovery

Link

http://www.tandfonline.com/doi/pdf/10.1517/17460440802564845

Reference99 articles.

1. From magic bullets to designed multiple ligands

2. Monotherapy versus Combination Therapy as First Line Treatment of Uncomplicated Arterial Hypertension

3. Designed Multiple Ligands. An Emerging Drug Discovery Paradigm

4. Playing dirty

5. The Physicochemical Challenges of Designing Multiple Ligands

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in the development of active hybrid molecules in the treatment of cardiovascular diseases;Bioorganic & Medicinal Chemistry;2022-05

2. Do nitric oxide-releasing drugs offer a potentially new paradigm for the management of cardiovascular risks in diabetes?;Expert Review of Cardiovascular Therapy;2014-04-11

3. Can nitric oxide-releasing hybrid drugs alleviate adverse cardiovascular risks?;Future Medicinal Chemistry;2013-03

4. Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives;Current Medicinal Chemistry;2012-07-01

5. Hydrogen sulphide: novel opportunity for drug discovery;Medicinal Research Reviews;2010-12-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3